Roche Holding AG Participation (RHHVF)

Roche Holding AG Participation (RHHVF) is a profit-participation certificate, or Genussschein, associated with Roche Holding AG and listed on OTC Markets. The instrument reflects the Swiss healthcare group’s underlying business, while the listed security itself should be viewed in the context of its participation structure rather than as ordinary common equity. Roche is active in pharmaceuticals and diagnostics across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. Its pharmaceutical business covers therapies for anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory disorders, and transplantation. The diagnostics segment includes in vitro tests for diseases such as cancer, diabetes, Covid-19, hepatitis, and human papillomavirus, as well as diagnostic instruments and digital health solutions. Founded in 1896, Roche is based in Basel, Switzerland.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap Free Float / Shares Outstanding Payout Ratio
OTC-RHHV.F
Not available
$505.81
13.7% Upside
Fair
Great
1.8%
October 22, 2026
355 B
82.1%
63.2%
Valuation • Fair Value

Roche Holding AG Participation (OTC-RHHV.F) Fair Value by Valuation Model

Review the valuation references currently available for Roche Holding AG Participation (OTC-RHHV.F).

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

$505.81

Analysts imply upside of 13.7%.

How to read these valuation models

Use the available valuation reference for Roche Holding AG Participation (OTC-RHHV.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Roche Holding AG Participation (OTC-RHHV.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

77.922 B

Current operating scale indicator.

EBITDA

29.66 B

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Roche Holding AG Participation (OTC-RHHV.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Roche Holding AG Participation (OTC-RHHV.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Roche Holding AG Participation (OTC-RHHV.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Roche Holding AG Participation (OTC-RHHV.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 22, 2026

Days to Earnings

30

Dividend Yield

1.8%

Current income yield reference.

Payout Ratio

63.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Roche Holding AG Participation (OTC-RHHV.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Roche Holding AG Participation (OTC-RHHV.F) Stock Forecast & Technical Outlook

Review Roche Holding AG Participation (OTC-RHHV.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Roche Holding AG Participation (OTC-RHHV.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Roche Holding AG Participation (OTC-RHHV.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Roche Holding AG Participation (OTC-RHHV.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Roche Holding AG Participation (OTC-RHHV.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Roche Holding AG Participation (OTC-RHHV.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Roche Holding AG Participation (OTC-RHHV.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Roche Holding AG Participation (OTC-RHHV.F) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Roche Holding AG Participation (OTC-RHHV.F) Stock FAQ

Data-supported answers about Roche Holding AG Participation (OTC-RHHV.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Analyst Target
$505.81
Implied upside 13.7%
Financial Health
Great
Current financial-health read

A reliable fair value estimate is not currently available for Roche Holding AG Participation (OTC-RHHV.F). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The available analyst price target for Roche Holding AG Participation (OTC-RHHV.F) is $505.81. The analyst target implies estimated upside of 13.7%.

The current financial health read for Roche Holding AG Participation (OTC-RHHV.F) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Roche Holding AG Participation (OTC-RHHV.F) is October 22, 2026.

Based on the current data, dividend yield is 1.8%.

The current market capitalization listed for Roche Holding AG Participation is 355 B.

The ticker symbol for Roche Holding AG Participation is OTC-RHHV.F, and the stock is listed on OTC Markets.

Roche Holding AG Participation (OTC-RHHV.F) is listed on OTC Markets.

The free float listed for Roche Holding AG Participation is 82.1%. Free float helps investors understand how much of the share base is available for public trading.